Company News
KangaBio's Novel Drug KGX105 Obtains IND Approval from CDE
2026-06-23
Company News
KangaBio Announces FDA IND Clearance for KGX105, AACR Acceptance of KGX101 Clinical Data Abstract, and Completion of Over $15 Million in Pre-A+ Financing
2026-03-03
Company News
Good News | KangaBio Wins First Prize at the 2024 Pudong New Area "Pearl Cup" Entrepreneurship Competition
2025-02-28
Company News
KGX101, an Innovative IL-12 Prodrug by Kangabio, Completes First Patient Dosing in China
2024-12-10
Company News
KangaBio present preclinical data of IL-12 prodrug KGX101 at AACR 2024
2024-04-10
Company News
KangaBio's IL-12 Prodrug KGX101: dosing of the first patient was completed
2023-12-13
Company News
KangaBio's new generation IL-12 prodrug has been approved for IND application in the United States
2023-10-26
Company News
Dr. Weidong Jiang embarks on his second entrepreneurial venture, with his newly founded KangaBio securing over RMB 100 million in Pre-Series A financing.
2023-06-23
Company News
Shanghai KangaBio Opening Ceremony
2021-08-12